November 28, 2016 - By Hazel Jackson
Craig-Hallum started coverage on shares of Teladoc (TDOC) in a note sent to clients and investors on Monday, 28 November. The financial company issued “Buy” rating on TDOC stock.
The stock decreased 0.82% or $0.15 on November 25, hitting $18.15. Teladoc Inc (TDOC) has risen 51.25% since April 25, 2016 and is uptrending. It has outperformed by 45.24% the S&P500.
Analysts await Teladoc Inc (NYSE:TDOC) to report earnings on March, 1. They expect $-0.34 earnings per share, up 12.82% or $0.05 from last year’s $-0.39 per share. After $-0.33 actual earnings per share reported by Teladoc Inc for the previous quarter, Wall Street now forecasts 3.03% negative EPS growth.
Teladoc, Inc., together with its subsidiaries, is a telehealth company. The company has a market cap of $828.64 million. The Firm offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. It currently has negative earnings. The Firm operates through health services segment.
According to Zacks Investment Research, “Teladoc, Inc. is a telehealth company. The company offers telehealth services via mobile devices, internet, video and phone to clients primarily in the United States. Its solution connects consumers with physicians and behavioral health professionals to treat upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. Teladoc, Inc. is based in Dallas, Texas.”
Teladoc, Inc., together with its subsidiaries, incorporated on October 16, 2008, is a telehealth company. The Firm offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Firm operates through health services segment. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. It serves over 6,000 employers, health plans, health systems and other entities. These Clients collectively purchase access to its solution for approximately 10 million Members. It has over 30 health plans as Clients.
More recent Teladoc Inc (NYSE:TDOC) news were published by: Marketwatch.com which released: “/quotes/zigman/3870025/realtime” on June 04, 2015. Also Wsj.com published the news titled: “Why Teladoc Needs Medical Attention” on October 04, 2015. Quotes.Wsj.com‘s news article titled: “Teladoc Inc. TDOC (US: NYSE)” with publication date: June 18, 2015 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.